Avalon GloboCare Corp (NASDAQ:ALBT) said it will launch its KetoAir breathalyzer device at the KetoCon Austin 2023 conference.
KetoAir is a companion diagnostic and monitoring device that uses an artificial intelligence (AI) nutritionist consultation for ketogenic dietary management.
Freehold, New Jersey-based Avalon recently announced a partnership with Qi Diagnostics to exclusively distribute breathalyzer device in North America, South America, the UK and the EU
This will be the official commercial launch of KetoAir in North America, CEO David Jin told investors.
“Initially, we will target the diabetes reversal and obesity management markets, since the ketogenic diet is an effective treatment option for both diabetes and weight management,” Jin said in a statement.
The KetoAir breathalyzer measures the keto status and logs the diet records in the KetoAir app, Jin told shareholders.
KetoAir’s AI nutritionist analyzes the dietary plan and becomes something of a consultant, providing personalized nutritional and exercise recommendations to help achieve the user’s health goals.
“KetoAir is the first breathalyzer on the market that uses an AI nutritionist bundled with the nanosensor-based breathalyzer for ketogenic health management…We encourage everyone to stop by our booth and try out KetoAir™ for themselves,” Jin added.
The conference is being held between April 21 to 23, 2023 in Austin, Texas. Avalon will showcase the KetoAir in booth #523.
Contact Angela at angela@proactiveinvestors.com
Follow her on Twitter @AHarmantas